GCH1 and cardiovascular disorder: More recently, it has demonstrated that statins may inhibit aberrant miR-133a expression in the vascular endothelium to prevent endothelial dysfunction and consequent cardiovascular diseases by targeting GTP cyclohydrolase 1 (GCH1) [140].